Find all our consortium research and publications related to the Enabling Access to Medical Innovation for All project, including reports, advocacy materials, expert analysis, and more.

Reports

Wemos and Afya na Haki | BioNTech Africa: in the region, but also for and by the region? | June 2024 (Webinar recording available here)

UAEM | White Paper: Early Action for Equitable Access | Spring 2024

Briefing Papers

Medicines Law & Policy | It is not too late to solve the know-how problem in the WHO Pandemic Accord | March 2024

Medicines Law & Policy | The European Parliament has now explicitly acknowledged the know-how problem too: time to include a workable solution in the draft Pandemic Accord | March 2024

Knowledge Ecology International | Briefing Note: What measures do US competition authorities refer to in technology transfer mandates | March 2024

Medicines Law & Policy | European Parliament’s amendments make the Regulation for EU-wide compulsory licensing difficult to use and need to be rolled back | April 2024

Medicines Law & Policy | The last mile: A few suggestions for the WHO Pandemic Agreement’s last two weeks of talks | April 2024

Medicines Law & Policy | Pressure from European countries related to the use of TRIPS Flexibilities | May 2024

Statements

Health Action International | Statement to INB8 | February 2024

Health Action International | INB8: Statement to the second Joint Plenary Session Working Group on the International Health Regulations and Intergovernmental Negotiating Body | February 2024

Health Action International | Statement to INB9 | March 2024

Wemos and Health Action International | Joint Call to European Parliament: Take Control to Ensure Access to Medicines in the EU | April 2024

UAEM | Comments on Proposed March-In Rights Framework | Spring 2024

Wemos | Statement in German national parliament: close the vaccine gap in Africa | June 2024

UAEM | Enhancing Access to NIH-Owned Innovations: UAEM’s Vision and Recommendations | July 2024

Knowledge Ecology International | INB11: KEI statement on Article 13 (on sanctions) | September 2024

News items

Wemos | Campaign for fair medicine prices: play Monopoly, the Medicine Edition | January 2024

Wemos | Investing in global health is investing in the Netherlands | January 2024

Medicines Law & Policy | Fair Medicines Pricing requires addressing monopolies and increasing transparency in pharmaceutical markets | February 2024

Medicines Law & Policy | Written remarks submitted to the OHCHR following the Expert Workshop on the key challenges and new developments in ensuring access to medicines, vaccines and other health products | March 2024

Wemos | Reflection on debate Dutch global health strategy | April 2024

Wemos | Explainer video: how we can ensure fair prices for new medicines | April 2024

Medicines Law & Policy | Continuing to ignore the problem of the know-how gap won’t make it go away | May 2024

Wemos | Questions and answers around the pandemic accord and the International Health Regulations | May 2024

Wemos | Pandemic Accord in its final stage: a basis for further discussions | May 2024

Wemos | Monopoly, the Medicine Edition presented to Dutch MPs | May 2024

Wemos | Netherlands should donate mpox vaccines | September 2024